SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-006376
Filing Date
2010-02-11
Accepted
2010-02-11 12:20:44
Documents
6
Period of Report
2010-02-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-3008_28k.htm 8-K 54733
2 EX-10.1 a10-3008_2ex10d1.htm EX-10.1 17664
3 EX-10.2 a10-3008_2ex10d2.htm EX-10.2 18471
4 EX-10.3 a10-3008_2ex10d3.htm EX-10.3 143851
5 EX-10.4 a10-3008_2ex10d4.htm EX-10.4 111019
6 EX-10.5 a10-3008_2ex10d5.htm EX-10.5 42759
  Complete submission text file 0001104659-10-006376.txt   390284
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 10590383
SIC: 2834 Pharmaceutical Preparations